Bone/Mineral Metabolism News

Long-term adherence to healthful or unhealthful plant-based diets was not associated with risk for hip fracture among postmenopausal women, according to cohort study results published in JAMA Network Open.

In this video exclusive, Nicole Gomez, MD, talks with Caroline T. Nguyen, MD, about diagnosing and managing thyroid dysfunction in the postpartum period.

In this video exclusive, Caroline T. Nguyen, MD, talks with Cynthia A. Stuenkel, MD, MSCP, about diagnosing primary ovarian insufficiency, a condition similar to but different from menopause among women younger than 40 years.

Living kidney donors had a lower overall risk for bone fractures following donation but experienced significantly more vertebral breaks vs. a control group, researchers found.

Exposure to higher levels of endocrine-disrupting chemicals may hinder bone development for children, adolescents and young adults, according to study findings published in Environmental Research.

The FDA has added a boxed warning for denosumab to advise patients with advanced chronic kidney disease of an increased risk for severe hypocalcemia, according to an FDA drug safety communication.

The FDA cleared a wearable vibration belt device as a non-pharmacologic treatment for postmenopausal women with osteopenia, according to an industry press release.

A once-weekly oral vitamin D supplementation did not reduce fracture risk over a 3-year follow-up among a group of children with vitamin D deficiency in Mongolia, according to findings published in The Lancet Diabetes & Endocrinology.

The identification of rare genetic variants that influence bone mineral density did not significantly improve fracture risk screening among a large group of adults, according to data published in Journal of Bone and Mineral Research.

Hormone therapy with transdermal estradiol may benefit bone and CV health and overall quality of life up to 20 years after hysterectomy, according to study results published in Menopause.